The Manila Times

4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer …

Prospective-trial analysis published in the Journal of the National Cancer Institute predicts residual cancer burden from ...
Seeking Alpha

Exclusive BAC Article: 4D Molecular Therapeutics; 52-Week Ph2B Data 4D-150 Wet-AMD Feb 2025, Ph 3 Trial Initiation Q1 Of 2025 And Catalysts

52-week interim results from phase 2b cohort of PRISM study, using 4D-150 for the treatment of patients with wet age-related macular degeneration, expected in February of 2025. Initiation of phase 3 ...
Business Wire

Research and Markets: 3D & 4D Technology Market Report 2014-2020 - 3D Product Type & Applications Analysis Post Avatar

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f6kr38/3d_and_4d) has announced the addition of the "3D & 4D Technology ...
Enid News & Eagle

4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM ...

24-week landmark safety and clinical activity data for 45 patients enrolled in the Population Extension cohort expected to be presented (N=30 at 3E10 vg/eye) Clinical data will be presented by Raj K.